Michal Mego

23PUBLICATIONS

40CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biologyHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (23)

Sort by Publication Date:

|Jun 02, 2026

Risk factors and causes of early death in germ cell tumors: a Global Society for Rare GU tumors study.

|Dec 04, 2025

Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy.

Michal Mego, Barbora Vlkova, Katarina Kalavska

|Jan 10, 2025

The effects of regular exercise on cognitive and cardiometabolic health in testicular cancer survivors subjected to platinum-based chemotherapy.

Ali Amiri, Lucia Slobodová, Radka Klepochová

|Jan 08, 2025

Insights into the Relationship Between the Gut Microbiome and Immune Checkpoint Inhibitors in Solid Tumors.

Sona Ciernikova, Aneta Sevcikova, Maria Novisedlakova

|Jan 23, 2024

Microbiome in Cancer Development and Treatment.

Sona Ciernikova, Aneta Sevcikova, Beata Mladosievicova

|Dec 23, 2023

Exploring the Role of the Gut and Intratumoral Microbiomes in Tumor Progression and Metastasis.

Aneta Sevcikova, Beata Mladosievicova, Michal Mego

Pageof 4

Frequent Collaborators

Sona Ciernikova

Michal Chovanec

Martin Janicko

Lubomir Skladany

Svetlana Adamcova-Selcanova

Svetlana Miklikova

Jana Plava

Silvia Schmidtova

Jakub Gazda

Sylvia Drazilova

Frequent Collaborators

Sona Ciernikova

Michal Chovanec

Martin Janicko

Lubomir Skladany